Skip to content

Inferior Vena Cava Pressure as Alternative to Hepatic Venous Pressure for EUS-guided Portal Pressure Gradient Measurement

Inferior Vena Cava Pressure as Alternative to Hepatic Venous Pressure for EUS-guided Portal Pressure Gradient Measurement

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07703540
Acronym
EUS-VEIN
Enrollment
40
Registered
2026-07-14
Start date
2026-02-01
Completion date
2026-05-15
Last updated
2026-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis, Liver Disease Chronic, Portal Hypertension

Keywords

EUS-PPG, EUS, Portal hypertension, Portal vein pressure, Clinically significant portal hypertension (CSPH), Inferior vena cava pressure, Endoscopic ultrasound-guided portal pressure gradient

Brief summary

This study investigates a new, simplified approach to measuring blood pressure within the liver (portal hypertension) using Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement (EUS-PPG). While this minimally invasive method traditionally relies on a hepatic vein as the baseline reference point, advanced liver scarring can make these veins twisted and highly difficult to access. To address this challenge, our study evaluates the Inferior Vena Cava (IVC)-the body's largest main vein-as an alternative reference site. Currently, it remains scientifically unproven whether the inferior vena cava or the hepatic vein provides the more reliable and accurate pressure reading for calculation, as anatomical distortion from cirrhosis can affect both areas differently. By measuring and comparing both venous compartments during a single, clinically scheduled endoscopy session, this study aims to determine if the pressures are truly interchangeable. Ultimately, this research will clarify which vessel serves as the optimal reference point, helping to establish a safer, more reliable diagnostic standard for patients with complex vascular anatomy.

Interventions

DIAGNOSTIC_TESTHVP-PPG and IVCP-PPG

During a clinically indicated endoscopic ultrasound (EUS), patients undergo portal pressure gradient (PPG) measurement using a linear-array echoendoscope and a dedicated needle system (22G or 25G). The intervention utilizes a transgastric approach to sequentially measure pressures in three vessels: a left intrahepatic portal vein branch, a hepatic vein, and the inferior vena cava (IVC). The IVC is safely punctured through a window covered by liver tissue. Pressures are measured in triplicate per vessel. This protocol uniquely calculates two distinct gradients within the same procedural session: HVP-PPG: Calculated as the mean portal vein pressure minus the mean hepatic vein pressure (HVP). IVCP-PPG: Calculated as the mean portal vein pressure minus the mean inferior vena cava pressure (IVCP).

Sponsors

University Hospital Muenster
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Consecutive adult patients (≥18 years) undergoing clinically indicated EUS-guided portal pressure gradient measurement

Exclusion criteria

* severe coagulopathy (INR \>2.0), thrombocytopenia (\<50,000/µL) * large-volume ascites * gastric varices precluding safe vascular puncture * known hepatic vein thrombosis or Budd-Chiari syndrome * altered IVC anatomy such as patients after liver transplantation with piggy-back anastomosis * contraindication to upper gastrointestinal endoscopy or sedation * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Agreement between mean hepatic vein pressure and mean inferior vena cava pressure measured during the same EUS-PPG sessionIntraproceduralBased on prior reproducibility data for EUS-guided portal pressure measurements, a predefined absolute difference of \>1 mmHg between HVP and IVCP was considered clinically relevant. Differences ≤1 mmHg after rounding to the nearest whole mmHg were considered hemodynamically equivalent, reflecting clinical pressure reporting practice.

Secondary

MeasureTime frame
Correlation between HVP and IVCP, Bland-Altman analysis of agreement and systematic biasIntraprocedural measurement
Agreement between PPG-HV and PPG-IVCIntraprocedural measurement
Reclassification across clinically significant portal hypertension thresholds (≥10 mmHg)Intraprocedural measurement
Intraprocedural variability of triplicate measurementsIntraprocedural measurement
Procedural adverse eventsUp to 72 hours

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 15, 2026